Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls
Open Access
- 5 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 10 (1), 1-12
- https://doi.org/10.1038/s41398-020-0737-6
Abstract
Bipolar disorder is a common, chronic psychiatric disorder. Despite high heritability, there is a paucity of identified genetic risk factors. Immune biomarkers are under more direct genetic influence than bipolar disorder. To explore the genetic associations with immune biomarker levels in cerebrospinal fluid (CSF) and blood serum which previously showed differences in bipolar disorder, we performed a study involving 291 individuals (184 bipolar disorder patients and 107 controls). The biomarkers assayed in both CSF and serum were: chitinase-3-like protein-1 (YKL-40), monocyte chemoattractant protein-1 (MCP-1), soluble cluster of differentiation (sCD14), tissue inhibitor of metalloproteinases-1 and 2 (TIMP-1 and TIMP-2). C-reactive protein (CRP) was only quantified in serum, and interleukin 8 (IL-8) measures were only available in CSF. Genome-wide association studies were conducted using PLINK for each of three genotyping waves and incorporated covariates for population substructure, age, sex, and body mass index (BMI). Results were combined by meta-analysis. Genome-wide significant associations were detected for all biomarkers except TIMP-1 and TIMP-2 in CSF. The strongest association in CSF was found for markers within the CNTNAP5 gene with YKL-40 (rs150248456, P = 2.84 × 10−10). The strongest association in serum was also for YKL-40 but localized to the FANCI gene (rs188263039, P = 5.80 × 10−26). This study revealed numerous biologically plausible genetic associations with immune biomarkers in CSF and blood serum. Importantly, the genetic variants regulating immune biomarker levels in CSF and blood serum differ. These results extend our knowledge of how biomarkers showing alterations in bipolar disorder are genetically regulated.This publication has 58 references indexed in Scilit:
- Genome-wide association analysis identifies 30 new susceptibility loci for schizophreniaNature Genetics, 2017
- Genome-wide association study identifies 112 new loci for body mass index in the Japanese populationNature Genetics, 2017
- Genome-wide association study reveals two new risk loci for bipolar disorderNature Communications, 2014
- A Genome-Wide Association Scan on the Levels of Markers of Inflammation in Sardinians Reveals Associations That Underpin Its Complex RegulationPLoS Genetics, 2012
- Replication of GWAS of bipolar disorder: association of SNPs near CDH7 with bipolar disorder and visual processingMolecular Psychiatry, 2009
- Convergent functional genomics of genome‐wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanismsNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2008
- High Concordance of Bipolar I Disorder in a Nationwide Sample of TwinsAmerican Journal of Psychiatry, 2004
- The Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar DepressionArchives of General Psychiatry, 2003
- A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II DisorderArchives of General Psychiatry, 2003
- The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I DisorderArchives of General Psychiatry, 2002